Business
Lineage Cell Therapeutics to Present at September 2025 Investor Conferences
CARLSBAD, Calif., September 02, 2025--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious neurological and ophthalmic conditions, today announced that Brian M. Culley, Lineage’s Chief Executive Officer, will be presenting at the H.C. Wainwright 27th Annual Global Investment Conference, on September 8, 2025, at 11:30am ET and at Baird's 2025 Global Healthcare Conference,
About this update from Lineage Cell Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1740,"height":360,"url":"https://media.zenfs.com/en/business-wire.com/8bc3f39bd74710117eccb88b5f84f89c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0_Ulsrbw2BGONPEtc9EjtQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE5OTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/8bc3f39bd74710117eccb88b5f84f89c","width":960,"height":199},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/iMzyaS5yGG6erQbwWabUpQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00OTY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/8bc3f39bd74710117eccb88b5f84f89c","width":1200,"height":248}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference Presentation on September 8, 2025 ","length":90,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Baird's 2025 Global Healthcare Conference Presentation on September 9, 2025","length":79,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":169,"olType":false},{"type":"text","content":"CARLSBAD, Calif., September 02, 2025--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious neurological and ophthalmic conditions, today announced that Brian M. Culley, Lineage’s Chief Executive Officer, will be presenting at the H.C. Wainwright 27th Annual Global Investment Conference, on September 8, 2025, at 11:30am ET and at Baird's 2025 Global Healthcare Conference, on September 9, 2025 at 12:50pm ET.","length":566,"tagName":"p"},{"type":"text","content":"Investors interested in scheduling an in-person meeting with the Lineage management team should contact their H.C. Wainwright or Robert W. Baird & Co. representatives directly. A replay of Lineage’s presentation from the H.C. Wainwright 27th Annual Global Investment Conference will be available on the Events and Presentations section of Lineage’s website, following the conclusion of the conference.","length":405,"tagName":"p"},{"type":"text","content":"About Lineage Cell Therapeutics, Inc.","length":37,"tagName":"p"},{"type":"text","content":"Lineage Cell Therapeutics is a clini...